CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
November 2020—The FDA has issued an emergency use authorization for Visby Medical’s single-use personal PCR device, a rapid test for detecting COVID-19.
The Visby Medical COVID-19 test is a palm-size device that provides results in less than 30 minutes. It has been authorized for the qualitative detection of SARS-CoV-2 RNA in nasopharyngeal, nasal, or mid-turbinate swabs collected by a health care provider, or nasal or mid-turbinate swabs self-collected in a health care setting from individuals who are suspected of having COVID-19 by their health care provider.
Pages: 1 2